improving mrd assessment and response criteria in dlbcl: insights into phased-seq
Published 1 year ago • 367 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
2:35
an update on mrd assessment and novel techniques used in the treatment of hematological malignancies
-
1:33
the difficulties of mrd detection in dlbcl
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
2:07
using mrd to improve patient outcomes
-
2:05
the value of mrd assessment in lymphoma
-
14:46
understanding diagnostics and genomics in lymphoma with eric hsi, md
-
2:11
perspectives on the treatment of patients with r/r multiple myeloma
-
27:48
sam and mom—"evaluation of the child with adhd"
-
3:12
an analysis of shared treatment decision-making in patients with r/r dlbcl
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
1:44
how mrd assessment can inform treatment decisions in aml
-
2:18
current and future perspectives for prognostication and mrd in hodgkin lymphoma
-
1:26
improving tools and techniques for mrd detection in hodgkin lymphoma
-
1:22
diagnostics and treatment outcomes from primary cbcl
-
2:33
insights into the results and implications of the commands & imerge studies in lr-mds
-
5:46
mrd: standardization and application
-
2:15
improving the specificity of molecular mrd detection
-
1:02
the changing standard of care in dlbcl
-
3:59
using enhanced ctdna profiling to identify molecular determinants of response in r/r mcl
-
2:13
mrd for decision making in follicular lymphoma
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials